Found 16 matching trials
Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients
PHASE4The purpose of this study is to determine whether standard medications appr...
Location
Joseph & Kathleen Bryan Alzheimer's Disease Research Unit
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
PHASE2The purpose of this research study is to measure the tolerability and preli...
Location
Kessler Institute for Rehabilitation
Subarachnoid Hemorrhage Recovery And Galantamine
PHASE1The purpose of this study is to examine the effects of the study drug--Gala...
Location
Houston Methodist Hospital Texas Medical Center
Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans
PHASE1Specific Aim 1: To test the hypothesis that prolonged (3-month) treatment w...
Galantamine Effects on Nicotine Responses in Smokers
PHASE1This will be a 2-4 week double-blind, placebo-controlled study. Twenty four...
Location
Department of Veterans Affairs
Vagal Stimulation in POTS
PHASE1The purpose of this study is to investigate how the electrical stimulation ...
Status
Active Not Recruiting
Location
Autonomic Dysfunction Center/ Vanderbilt University Medical Center
Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD)
NAExamination of the correlation between the cerebral bloodflow and the clini...
Location
Department of Psychiatry, University Bonn
A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease
PHASE3The purpose of this study is to compare the effectiveness and safety of 2 y...
Location
Multiple Locations
Galantamine Effects on Cognitive Function in Marijuana Users
PHASE1To evaluate galantamine's effects on cognitive performance in marijuana use...
Location
Department of Veterans Affairs
Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)
PHASE4Alzheimer's disease (AD) is characterized by progressive subcortical and co...
Location
Ludwig-Maximilian University of Munich